Polar Capital has launched a Healthcare Blue Chip fund as it expands the range run by Daniel Mahony and Gareth Powell's specialist team.
The fund, lead managed by Mahony and Powell (pictured), will invest in a portfolio of 25-30 blue chip stocks and seek to outperform the MSCI World Daily Total Return Net Health Care index. Sector exposure will encompass pharmaceuticals, biotechnology, medical device and healthcare services firms. The launch, which has been seeded by PSigma IM, follows Polar's November 2013 rollout of a Biotechnology fund for its healthcare team, which also runs the £488m Healthcare Opportunities fund and the Global Healthcare Growth and Income trust. Those funds have capitalised on the runaway retu...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
